Arbutus Biopharma (ABUS) Restructuring Costs (2015 - 2025)
Arbutus Biopharma's (ABUS) quarterly Restructuring Costs came in at $303000.0 in Q4 2025, up 218.95% year-on-year from $95000.0 in Q4 2024, and up 209.18% quarter-over-quarter from $98000.0 in Q3 2025.
Arbutus Biopharma (ABUS) Restructuring Costs (2015 - 2025) Analysis & Trends
Arbutus Biopharma has disclosed Restructuring Costs across 6 years of filings, most recently posting $303000.0 for Q4 2025.
- Restructuring Costs for Q4 2025 came in at $303000.0, up 218.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.8 million (down 20.46% YoY), and the FY2025 annual result was $12.9 million, up 247.82% from the prior year.
- Restructuring Costs came in at $303000.0 for Q4 2025 at Arbutus Biopharma, up from $98000.0 in the prior quarter.
- In the past five years, Restructuring Costs ranged from a high of $12.4 million in Q2 2025 to a low of $95000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Arbutus Biopharma | 882.62 Mn | 882.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 303,000.00 |
| Sep 30, 2025 | 98,000.00 |
| Jun 30, 2025 | 12.40 Mn |
| Mar 31, 2025 | 12.37 Mn |
| Dec 31, 2024 | 95,000.00 |
| Sep 30, 2024 | 3.63 Mn |
| Jun 30, 2020 | 7,000.00 |
| Mar 31, 2020 | 57,000.00 |
| Dec 31, 2019 | 123,000.00 |
| Sep 30, 2019 | 182,000.00 |
| Jun 30, 2019 | -266,000.00 |
| Mar 31, 2019 | 117,000.00 |
| Dec 31, 2018 | 1.09 Mn |
| Sep 30, 2018 | -492,000.00 |
| Jun 30, 2018 | 2.58 Mn |
| Mar 31, 2018 | 1.62 Mn |
| Jun 30, 2015 | 361,000.00 |
| Mar 31, 2015 | 9.30 Mn |